Get started
Author

Nicolas Carlos Kahn

Observed names: Kahn, N., Kahn, N.C., Kahn, Nicolas, Kahn, Nicolas C., N Kahn, N. Kahn, N., Kahn, N.C. Kahn, Nicolas C Kahn, Nicolas C. Kahn, Nicolas Kahn, Nicolas Carlos Kahn
ORCID: 0000-0002-5403-8069
Observed ORCID: 0000-0002-5403-8069
OpenAlex ID: A5020173096
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells
2020 · Soeren Lukassen, Robert Lorenz Chua, et al. · The EMBO Journal · 1,100
PDF
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
2021 · Jürgen Behr, Antje Prasse, et al. · The Lancet Respiratory Medicine · 520
Combined Endoscopic-Endobronchial Ultrasound-Guided Fine-Needle Aspiration of Mediastinal Lymph Nodes Through a Single Bronchoscope in 150 Patients With Suspected Lung Cancer
2010 · Felix J.F. Herth, Mark Krasnik, et al. · CHEST Journal · 276
The therapy of idiopathic pulmonary fibrosis: what is next?
2019 · Vivien Somogyi, Nazia Chaudhuri, et al. · European Respiratory Review · 265
PDF
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
2020 · Jürgen Behr, Antje Prasse, et al. · European Respiratory Journal · 189
PDF
Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study
2021 · Manuel Röhrich, Dominik Leitz, et al. · Journal of Nuclear Medicine · 169
PDF
LungPoint—A New Approach to Peripheral Lesions
2010 · Ralf Eberhardt, Nicolas Kahn, et al. · Journal of Thoracic Oncology · 129
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-Life Experience from a German Tertiary Referral Center for Interstitial Lung Diseases
2014 · Ute Oltmanns, Nicolas Kahn, et al. · Respiration · 128
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
2019 · Michael Kreuter, Jeff Swigris, et al. · Respiratory Research · 125
PDF
Hypoxic Epithelial Necrosis Triggers Neutrophilic Inflammation via IL-1 Receptor Signaling in Cystic Fibrosis Lung Disease
2015 · Benedikt Fritzsching, Zhe Zhou-Suckow, et al. · American Journal of Respiratory and Critical Care Medicine · 113
Endobronchial ultrasound-guided lymph node biopsy with transbronchial needle forceps: a pilot study
2011 · F.J.F. Herth, H. Schuler, et al. · European Respiratory Journal · 75
PDF
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe
2022 · Theodoros Karampitsakos, Paolo Spagnolo, et al. · Respirology · 67
Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection
2021 · Frederik Trinkmann, Michael Müller, et al. · European Respiratory Journal · 48
PDF
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
2019 · Sebastiano Emanuele Torrisi, Nicolas Kahn, et al. · BMC Pulmonary Medicine · 33
PDF
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme
2020 · Claudia Valenzuela, Sebastiano Emanuele Torrisi, et al. · Respiratory Research · 30
PDF
Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN
2020 · Carmen Veith, Milena Hristova, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 28
Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting
2021 · Sebastiano Emanuele Torrisi, Nicolas Kahn, et al. · Frontiers in Pharmacology · 27
Evolution and treatment of idiopathic pulmonary fibrosis
2020 · Sebastiano Emanuele Torrisi, Nicolas Kahn, et al. · La Presse Médicale · 27
‘Heat and Destroy’: Bronchoscopic-Guided Therapy of Peripheral Lung Lesions
2010 · Ralf Eberhardt, Nicolas Kahn, et al. · Respiration · 25
YouTube-videos for patient education in lymphangioleiomyomatosis?
2022 · Finn M. Wilkens, Claudia Ganter, et al. · Respiratory Research · 23
PDF
Optical coherence tomography detects structural abnormalitiesof the nasal mucosa in patients with cystic fibrosis
2015 · Ute Oltmanns, Karin Palmowski, et al. · Journal of Cystic Fibrosis · 23
PDF
C-proSP-B: A Possible Biomarker for Pulmonary Diseases?
2018 · Nicolas Kahn, Anne-Kathrin Rossler, et al. · Respiration · 22
Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)
2019 · Andreas Guenther, Antje Prasse, et al. · 20
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
2019 · Michael Kreuter, David J. Lederer, et al. · European Respiratory Journal · 19
PDF
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
2016 · Marc A. Schneider, Thomas Muley, et al. · Oncotarget · 19
PDF
Works count: 187
Citation count: 4,220
H-index: 22
I10-index: 35
Year
Topic
Type